Novartis news
The latest Novartis news, : Santander reports €194 million AI‑generated business value in first nine months of 2026.
The provided stories do not mention Novartis. Recent coverage focuses on corporate AI spending, Isomorphic Labs' cancer drug design, and Anthropic's biology lab. These reports detail AI applications in drug discovery and business operations, but contain no information regarding Novartis.
5 stories mentioning Novartis since 22 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Santander reports €194 million AI‑generated business value in first nine months of 2026
Corporate AI spending hit $581.7 billion in 2025, a 130% jump from the year before, according to Stanford HAI’s 2026 AI Index. Hyperscalers such as Microsoft, Amazon, Google and Meta are projected to invest $700…
4 sourcesfinance.yahoo.comCNBC Technologynote.com -
Isomorphic Labs aims to design cancer drugs with AI, plans human trials soon
Google DeepMind spinoff Isomorphic Labs, led by CEO Demis Hassabis and President Max Jaderberg, is using its AlphaFold-derived drug design engine to develop novel cancer, immune, and inflammatory disease treatments.…
1 sourcebusinessinsider.com -
Medical AI expands into rare‑disease drug discovery and virtual lab markets
DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation. Recursion Pharmaceuticals, a US biotech, reports encouraging Phase 1b/2…
1 sourceUnite.AI -
SAP begins Joule Work rollout and launches SAP Pay
SAP SE announced the start of its Joule Work customer rollout and the launch of SAP Pay at SAP Connect in Las Vegas on October 6, 2026. CEO Christian Klein described the move as a breakthrough for business AI, noting…
1 sourceUnite.AI -
Anthropic is setting up a biology lab where Claude guides robots in drug experiments
Anthropic is building a biology lab near San Francisco that will let its Claude system direct robots through drug‑discovery experiments, Reuters reported. The lab is intended to move AI‑driven chemistry beyond computer…
2 sourcesThe Verge AIThe Decoder
Questions about Novartis
What is the latest Novartis news?
As of 1 November 2026: Santander reports €194 million AI‑generated business value in first nine months of 2026. Corporate AI spending hit $581.7 billion in 2025, a 130% jump from the year before, according to Stanford HAI’s 2026 AI Index.
What is Novartis?
The provided stories do not mention Novartis. Recent coverage focuses on corporate AI spending, Isomorphic Labs' cancer drug design, and Anthropic's biology lab. These reports detail AI applications in drug discovery and business operations, but contain no information regarding Novartis.